In SELECT, men taking 200 mcg of selenium had more hair loss and skin rash than on a dummy capsule.
Trial · 8,752 + 8,696 analyzed; 35,533 randomized in 4 groups · Median 5.5 years · maker-supplied
Lippman et al., JAMA, 2009
Terms and sources
- In SELECT
- Comments on this trial were also published; we could not read them.
- men
- Men aged 50 or 55 and over in the US, Canada and Puerto Rico, with no prostate diagnosis at entry. 8,752 took selenium and 8,696 a dummy capsule.
- 200 mcg of selenium
- As L-selenomethionine. The trial's main outcomes were illnesses; those results are not in this list.
- more hair loss and skin rash
- Hair loss: 265 versus 206 men. Mild to moderate skin rash: 605 versus 516. Both differences were statistically significant. Nail changes, tiredness, nausea and bad breath did not differ significantly.
- maker-supplied
- The US National Institutes of Health funded the trial. Perrigo, Sabinsa, Tishcon and DSM Nutritional Products provided the study agents and packaging.
Study · Free full text · about 35 min to read
Our estimate at about 200 words a minute, from the PMC full text.
Study summary
This report of the SELECT trial compared 200 mcg of selenium a day with a dummy capsule. The selenium was L-selenomethionine. The men were aged 50 or 55 and over. Over a median 5.5 years, 8,752 men took selenium and 8,696 the dummy. Hair loss was reported by 265 versus 206 men. Mild to moderate skin rash was reported by 605 versus 516. Both differences were statistically significant. Nail changes, tiredness and nausea did not differ significantly. Funding: NIH; four companies provided the study agents.
In 261 adults on selenomethionine for a year, blood selenium rose with dose; selenoprotein P did not.
Trial · 261 people · 12 months · maker-supplied
Combs et al., British Journal of Nutrition, 2012
Terms and sources
- 261 adults
- Healthy US men and women; 0, 50, 100 or 200 mcg of selenium a day as L-selenomethionine in capsules. The 0 mcg capsule held only the filler. 243 finished.
- blood selenium rose with dose
- Plasma, urine and cheek-cell selenium rose with dose and leveled off by 9–12 months. Urine selenium rose more in women than in men, and differed by a gene variant.
- selenoprotein P did not
- Glutathione peroxidase activity in plasma did not change either. The authors call this group of relatively high selenium status.
- maker-supplied
- Sabinsa Corporation supplied the selenomethionine capsules. US Department of Agriculture, US government and German research grants paid for the work. The authors declared no competing interests.
Study · Abstract only · about 29 min to read
Our estimate at about 200 words a minute, from the full text we read on the publisher's site. We do not know if it is free to read.
Study summary
This year-long trial gave 261 healthy US adults L-selenomethionine capsules. Doses were 0, 50, 100 or 200 mcg of selenium a day. 243 finished. Selenium in blood, urine and cheek cells rose with dose and leveled off by 9–12 months. Selenoprotein P and plasma glutathione peroxidase activity did not change. Urine selenium rose more in women than in men. Sabinsa supplied the capsules; US and German government grants paid for the work.
In 59 adults, blood selenium rose about 61–64% on selenomethionine or Brazil nuts and 8% on a dummy supplement.
Trial · 59 people · 12 weeks · funding not stated
Thomson et al., American Journal of Clinical Nutrition, 2008
Terms and sources
- 59 adults
- New Zealand adults, 12 weeks. Groups took 100 mcg of selenium as selenomethionine, 2 Brazil nuts a day, or a dummy supplement. The nuts gave about 53 mcg of selenium a day, possible range 20–84 mcg.
- blood selenium rose
- Plasma selenium rose 64.2% with nuts, 61.0% with selenomethionine and 7.6% with the dummy supplement. Nuts and selenomethionine differed from the dummy group, not from each other. Plasma glutathione peroxidase also rose with both versus the dummy. Whole-blood glutathione peroxidase rose more with nuts than with either.
- a dummy supplement
- The abstract does not describe the dummy supplement.
- funding not stated
- We could not read the funding section. PubMed tags it as funded by a non-US government source. The first author is at the University of Otago.
Study · Abstract only · about 2 min to read
Our estimate at about 200 words a minute, from the abstract.
Study summary
This trial compared Brazil nuts with selenomethionine in 59 New Zealand adults for 12 weeks. Groups ate 2 Brazil nuts a day, took 100 mcg of selenium as selenomethionine, or took a dummy supplement. The nuts gave about 53 mcg a day. Plasma selenium rose about 64% with nuts and 61% with selenomethionine, versus 8% with the dummy. Plasma glutathione peroxidase rose in both groups versus the dummy. Whole-blood glutathione peroxidase rose more with nuts. Funding: not read.
In men, blood selenium rose on selenomethionine and selenium yeast; two oxidation markers fell only on the higher yeast dose.
Trial · 69 analyzed · 9 months · maker-funded
Richie et al., Cancer Prevention Research, 2014
Terms and sources
- In men
- Healthy nonsmoking US men aged 23–78. 130 were randomized and 69 who finished were analyzed. Five were removed for adverse events, three in selenium groups; none among those who finished was serious.
- blood selenium rose
- Plasma selenium rose 93% with selenomethionine, 54% with 200 mcg of yeast and 86% with 285 mcg. All differed from the dummy group. Levels returned to the start 3 months after stopping.
- selenium yeast
- Groups for 9 months: 200 mcg of selenium as selenomethionine, or 200 or 285 mcg as selenium yeast (SelenoExcell). The dummy capsule held yeast without added selenium.
- two oxidation markers
- Urine markers of fat and DNA oxidation fell 28% and 34% with 285 mcg of yeast. They did not change with selenomethionine, 200 mcg of yeast or the dummy capsule.
- the higher yeast dose
- The article gives P < 0.05 for these falls without naming the comparison. They were largest in men with the lowest starting selenium. Blood glutathione, blood sugar and a prostate marker did not change. A commentary on this trial was also published. Its summary discusses the wider topic and does not dispute these results.
- maker-funded
- A US government (NIH) grant funded the trial. Cypress Systems provided the SelenoExcell yeast and partly paid for selenium analyses. Cypress had no role in design, analysis or writing.
Study · Free full text · about 23 min to read
Our estimate at about 200 words a minute, from the PMC full text.
Study summary
This trial compared selenomethionine with selenium yeast in healthy nonsmoking US men aged 23–78 for 9 months. 130 were randomized; 69 who finished were analyzed. Plasma selenium rose 93% with 200 mcg of selenomethionine, 54% with 200 mcg of yeast and 86% with 285 mcg. Two urine oxidation markers fell 28–34% only with 285 mcg of yeast. Blood sugar and a prostate marker did not change. Funding: a US government grant; Cypress Systems provided the selenium yeast and partly paid for analyses.
In 501 adults aged 60–74, mood scores on selenium yeast for 6 months did not differ from dummy yeast.
Trial · 501 people · 6 months · funding not stated
Rayman et al., Biological Psychiatry, 2006
Terms and sources
- 501 adults aged 60–74
- UK adults, double-blind. 100, 200 or 300 mcg of selenium a day as selenium yeast, or yeast without added selenium.
- mood scores
- Profile of Mood States questionnaire; 448 people filled it in at the start and at 6 months. Total mood: 163, 161, 162 and 162 for the dummy, 100, 200 and 300 mcg groups.
- did not differ from dummy yeast
- Quality-of-life scores also did not differ. Plasma selenium rose from about 90 ng/g to 144, 191 and 227 ng/g in the three selenium groups. The dummy group stayed at 91.
- funding not stated
- We could not read the funding section. The first author is at the University of Surrey. A later report of this trial names a UK charity and the university as funders.
Study · Abstract only · about 2 min to read
Our estimate at about 200 words a minute, from the abstract.
Study summary
This trial tested selenium and mood in 501 UK adults aged 60–74. They took 100, 200 or 300 mcg of selenium a day as selenium yeast, or dummy yeast, for 6 months. Plasma selenium rose with dose. Mood scores on a standard questionnaire did not differ between groups; 448 people completed it twice. Quality-of-life scores also did not differ. Funding: not read; a later report of the trial names a UK charity and the University of Surrey.
In 24 men in 10 weeks of endurance training, aerobic gains with selenium did not differ from a dummy supplement.
Trial · 24 people · 10 weeks · funding not stated
Tessier et al., Medicine and Science in Sports and Exercise, 1995
Terms and sources
- 24 men
- Healthy young men, double-blind; 12 took selenium and 12 a dummy supplement. The abstract does not give the dose. Two other reports of what appears to be the same trial give 180 mcg and 240 mcg.
- aerobic gains
- Maximal aerobic power and endurance capacity rose with training in both groups. Resting plasma glutathione peroxidase rose with selenium; the abstract does not say against which group.
- funding not stated
- We could not read the funding section. PubMed tags it as funded by a non-US government source. The first author is at the University of Nice.
Study · Abstract only · about 2 min to read
Our estimate at about 200 words a minute, from the abstract.
Study summary
This trial tested selenium during endurance training in 24 healthy young men for 10 weeks. 12 took selenium and 12 a dummy supplement, double-blind. Aerobic power and endurance rose with training in both groups, and selenium did not change performance. Resting plasma glutathione peroxidase rose with selenium. The abstract does not give the dose; other reports of the trial give 180 or 240 mcg. Funding: not read.
In 491 adults aged 60–74, two thyroid blood tests fell slightly with selenium yeast dose over 5 years.
Trial · 491 people · 5 years · funding not stated
Winther et al., European Journal of Endocrinology, 2015
Terms and sources
- 491 adults aged 60–74
- Danish adults, double-blind. 100, 200 or 300 mcg of selenium a day as selenium yeast, or matching dummy yeast tablets. 361 finished 5 years.
- over 5 years
- A later report followed this trial for about 15 years from the start. Deaths from any cause were higher with 300 mcg than with dummy tablets over that period (hazard ratio 1.59). At 5 years, the difference was not statistically significant. 100 and 200 mcg did not differ significantly. Rayman et al., Free Radical Biology and Medicine, 2018.
- two thyroid blood tests fell slightly
- Versus the dummy group, TSH fell by 0.066 mIU/L per 100 mcg a day. Free T4 fell by 0.11 pmol/L per 100 mcg. The authors call the effect minute. Free T3 did not change.
- funding not stated
- We could not read the funding section. The authors are at Odense University Hospital and the University of Southern Denmark.
Study · Abstract only · about 2 min to read
Our estimate at about 200 words a minute, from the abstract.
Study summary
In this trial, 491 Danish adults aged 60–74 took selenium yeast daily for 5 years. Doses were 100, 200 or 300 mcg. The comparison group took dummy yeast tablets. Blood selenium rose with dose. Two thyroid blood tests, TSH and free T4, fell slightly with dose versus the dummy group. The authors call the effect minute. Free T3 did not change. 361 people finished. A later report found more deaths from any cause over about 15 years with 300 mcg than with dummy tablets. Funding: not read.
In 60 men, glutathione peroxidase rose and a prostate marker fell on selenium glycinate; the abstract gives no comparison numbers.
Trial · 60 people · 6 weeks · funding not stated
Zhang et al., Nutrition Research, 2011
Terms and sources
- 60 men
- Healthy middle-aged US men. 30 took 200 mcg of selenium a day as selenium glycinate for 6 weeks, and 30 a dummy supplement.
- glutathione peroxidase rose
- Activity in red blood cells and in plasma. The authors write that the rises were not extremely large.
- a prostate marker fell
- Prostate-specific antigen (PSA), a blood test.
- the abstract gives no comparison numbers
- It says the dummy supplement did not give the same changes in 30 other men.
- funding not stated
- We could not read the funding section. The first author is at Ohio State University.
Study · Abstract only · about 2 min to read
Our estimate at about 200 words a minute, from the abstract.
Study summary
This trial gave 30 healthy middle-aged US men 200 mcg of selenium a day as selenium glycinate for 6 weeks. 30 others took a dummy supplement. In the selenium group, glutathione peroxidase activity in red blood cells and plasma rose. A prostate blood marker (PSA) fell. The abstract says the dummy did not give the same changes, without numbers or a test. Funding: not read.